James D. Gustafson has served as a Vice President since January 1, 1994, and has been responsible for our Quality Assurance and Regulatory/Clinical Affairs since June 1993. In August 2001, Mr. Gustafson assumed responsibility research, development, and engineering functions, and in August 2005 assumed responsibility for all clinical evaluation activities, and was designated Chief Quality Officer.
